# Miglustat

NDC: 68475-204
Generic name: Miglustat
Labeler / Manufacturer: Navinta LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250507

FDA application: ANDA219111

## Active ingredients

- MIGLUSTAT: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68475-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68475-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa9a3ab6-2376-4b52-9e54-15dc87f25260